Stock VLOV INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company VLOV Inc. Other OTC

Equities

US9182583024

Pharmaceuticals

End-of-day quote Other OTC
Other stock markets
- USD - Intraday chart for VLOV Inc.
2020 PAO Group, Inc. completed the acquisition of NCM Biotech from Kali, Inc.. CI
2020 PAO Group, Inc. agreed to acquire NCM Biotech from Kali, Inc.. CI

Business Summary

Kali, Inc. is a pharmaceutical company. The Company research and development of treatments for various illnesses, diseases and chronic pain as a symptom of various diagnoses. It also concentrates on the development of health and wellness therapies.

Sales per Business

USD in Million2017Weight2018Weight Delta
Pharmaceuticals
100.0 %
0 100.0 % 0 100.0 % -3.44%

Sales per region

USD in Million2017Weight2018Weight Delta
China
100.0 %
0 100.0 % 0 100.0 % -3.44%

Managers

Managers TitleAgeSince
Frederick Ferri CEO
 Chief Executive Officer - 18-12-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 285,133,954 282,282,614 ( 99.00 %) 0 98.86 %
Stock B 0 394,478 0 0

Company contact information

Kali, Inc.

8300 Douglas Avenue Suite 800

75225, Dallas

+

http://www.kali-extracts.com
address VLOV Inc.

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
NOVARTIS AG Stock Novartis AG
+9.78% 210B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. KALY Stock
  4. Stock
  5. Company VLOV Inc.